iShares Trust - iShares U.S. Pharmaceuticals ETF announced audited earnings results for the full year ended March 31, 2019. For the full year, the company announced net investment income was USD 4,511,894 compared to USD 8,958,332 a year ago. Net increase in net assets resulting from operations was USD 17,346,324 compared to USD 10,098,242 a year ago.